Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Northwest Biotherapeutics

Northwest Biotherapeutics reported $1.08M in Ordinary Share Capital for its fiscal quarter ending in March of 2023.

Ordinary Share Capital Change
Agenus AGEN:US USD 3.42M 361K
AstraZeneca AZN:LN USD 387M 0
Celldex Therapeutics CLDX:US USD 47K 0
CTI Biopharma CTIC:US USD 132K 1000
Eisai 4523:JP JPY 44.99B 0
Infinity Pharmaceuticals INFI:US USD 89K 0
Mirati Therapeutics MRTX:US USD 58K 0
Northwest Biotherapeutics NWBO:US USD 1.08M 15K
Plus Therapeutics, Inc. CYTX:US USD 36K 2K
Roche Holding ROG:VX CHF 107M 0